Related Experiment Video
Updated: Dec 17, 2025

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Using big data to retrospectively validate the COMPASS-CAT risk assessment model: considerations on methodology
Ilias Nikolakopoulos1, Soheila Nourabadi1, Joanna B Eldredge1
1Department of Medicine, Anticoagulation and Clinical Thrombosis Services, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, The Feinstein Institute for Medical Research, Northwell Health at Lenox Hill Hospital, 130 E 77th St, New York, NY, USA.
This study details challenges in externally validating the COMPASS-CAT risk model for cancer-associated thrombosis using big data. It outlines methods to ensure reliable validation for clinical use.
Area of Science:
- Medical Informatics
- Clinical Epidemiology
- Health Services Research
Background:
- External validation is crucial for clinical prediction model adoption.
- Methodologically sound external validation studies are infrequent.
- Large datasets can mitigate validation failures but require transparent reporting.
Purpose of the Study:
- To describe methodological challenges in the first retrospective external validation of the COMPASS-CAT Risk Assessment Model using multiple big datasets.
- To present a structured plan for overcoming challenges and reducing bias in external validation.
- To ensure the validation study adheres to prediction model reporting guidelines.
Main Methods:
- Utilized multiple large, real-world datasets for retrospective external validation.
- Addressed challenges in defining time-sensitive variables and outcome measures.
- Developed validated definitions from administrative codes in non-research databases.
Main Results:
- Successfully performed the first retrospective external validation of the COMPASS-CAT model.
- Identified and addressed key methodological hurdles in big data validation.
- Established a framework for bias reduction in external validation studies.
Conclusions:
- External validation of prediction models using big data presents unique methodological challenges.
- A structured approach is essential for rigorous validation and reliable reporting.
- This study provides a roadmap for conducting robust external validation of cancer-associated thrombosis risk models.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...

